6-Aminocaproic acid

Research use only, not for human use.

6-Aminocaproic acid is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.

6-Aminocaproic acid is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.(In Vitro):6-Aminocaproic acid (20-180 μg/mL) inhibits fibrinolysis in plasma of Asian elephants, with an effective concentration of 61.5 μg/mL.6-Aminocaproic acid can be used as a hydrophobic linker to improve near-infrared fluorescence imaging and photothermal cancer therapy of PEGylated indocyanine green.(In Vivo):6-Aminocaproic acid (20-100 mg/kg; a single p.o.) inhibits fibrinolysis at all doses tested in dogs.6-Aminocaproic acid (20-100 mg/kg; a single p.o.) is rapidly absorbed (Tmax=1 h) and eliminated rapidly in dogs.

6-Aminocaproic acid (20-180 μg/mL) inhibits fibrinolysis in plasma of Asian elephants, with an effective concentration of 61.5 μg/mL.6-Aminocaproic acid can be used as a hydrophobic linker to improve near-infrared fluorescence imaging and photothermal cancer therapy of PEGylated indocyanine green.

6-Aminocaproic acid (20-100 mg/kg; a single p.o.) inhibits fibrinolysis at all doses tested in dogs.6-Aminocaproic acid (20-100 mg/kg; a single p.o.) is rapidly absorbed (Tmax=1 h) and eliminated rapidly in dogs.

ε-Aminocaproic Acid | EACA | NSC 26154 | NSC 212532 | NSC 400230

Others

Other Targets

Plasminogen

Metabolic Disease

——

60-32-2

131.18

C6H13NO2

>98% (HPLC)

Ethanol: 1 mg/mL (7.62 mM); Water: 26 mg/mL (198.21 mM); DMSO: 6 mg/mL (45.74 mM)

O=C(O)CCCCCN

Aminocaproic acid

(-20℃)

With Ice Pack

≥ 2 years